Picture EBD Group World of Partnering Opportunities 650x100px

Product › Details

Defitelio®

	Next higher product group	defibrotide
	Status	2013-10-22 registration start
	Organisation	Gentium S.p.A. (Nasdaq: GENT)
	Group	Jazz Pharmaceuticals (Group)

Record changed: 2023-07-10

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for pharmaceutical_oo

[1] Idorsia Ltd.. (3/18/24). "Press Release: Idorsia and Viatris Successfully Close the Transaction for the Global Research and Development Collaboration". Allschwil....
[2] Idorsia Ltd.. (2/28/24). "Press Release: Idorsia and Viatris Enter into a Significant Global Research and Development Collaboration". Allschwil....
[3] Santhera Pharmaceuticals Holding AG. (10/27/23). "Press Release: Santhera Receives U.S. FDA Approval of AGAMREE® (vamorolone) for the Treatment of Duchenne Muscular Dystrophy [Ad hoc announcement pursuant to Art. 53 LR]". Pratteln....
[4] Santhera Pharmaceuticals Holding AG. (6/20/23). "Press Release: Santhera Grants Exclusive North America License for Vamorolone to Catalyst Pharmaceuticals in Deal Valued at up to USD 231 Million Plus Royalties [Ad hoc announcement pursuant to Art. 53 LR]...
[5] ObsEva S.A.. (11/22/22). "Press Release: ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million". Geneva....
[6] Genfit S.A.. (9/19/22). "Press Release: Genfit to Acquire Clinical-stage Biopharmaceutical Company Versantis, Expanding Its Portfolio in Liver Diseases". Lille & Cambridge, MA....
[7] Santhera Pharmaceuticals Holding AG. (1/4/22). "Press Release: Santhera Enters into Exclusive License Agreement with Sperogenix for Vamorolone in Rare Diseases in the Greater China Region". Pratteln....
[8] Relief Therapeutics Holding AG. (11/30/21). "Press Release: Relief Therapeutics Announces Executive Changes". Geneva....
[9] Santhera Pharmaceuticals Holding AG. (11/4/21). "Press Release: Santhera Appoints Stephanie Brown as President North America and Member of the Executive Management Team". Pratteln....
[10] Idorsia Ltd.. (10/11/21). "Press Release: Idorsia Announces the Results of MODIFY, a Phase 3 Study of Lucerastat in Fabry Disease". Allschwil....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)